February 28, 2024 – Notice of Annual General Meeting of Shareholders and Information Circular
February 10, 2025 – Notice of Availability of Proxy Materials for Annual General Meeting
February 10, 2025 – Form of Proxy
February 10, 2025 – Financial Statements Request Form
January 21, 2025 – Condensed Interim Consolidated Financial Statements – Q1 ending November 30, 2024
Download our Corporate Presentation
© 2023 ME Therapeutics All Rights Reserved.
